A Study Comparing User Experience of Different Delivery Devices for Glucagon

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

January 3, 2019

Study Completion Date

January 3, 2019

Conditions

Healthy

Interventions

DEVICE

Nasal Glucagon Device (NG)

NG devices will be provided empty of drug product

DEVICE

GEK

Used to administer glucagon intramuscularly (IM)

DRUG

IM Glucagon

Administered IM via GEK

Trial Locations (1)

High Point Clinical Trials Center, High Point

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03765502 - A Study Comparing User Experience of Different Delivery Devices for Glucagon | Biotech Hunter | Biotech Hunter